SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10047	Companies
204817	Keywords
135071	Articles
108593	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/21/2024 at 07:00, 1 year 8 months ago

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025

Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF

published on 06/12/2024 at 20:24, 1 year 9 months ago

Sanofi: Information on voting rights and shares - May 2024

Voting Rights Investors Actions Sanofi May 2024
PRESS RELEASE

published on 06/12/2024 at 20:19, 1 year 9 months ago

Sanofi: Information concerning the total number of voting rights and shares – May 2024
Sanofi discloses total number of voting rights and shares as per French commercial code and stock market authority regulations. Details available on Sanofi's website

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 06/03/2024 at 22:20, 1 year 9 months ago

Phase III study: Sarclisa improves progression-free survival of patients with multiple myeloma

Multiple Myeloma Sarclisa ASCO Phase III Study Progression-free Survival
PRESS RELEASE

published on 06/03/2024 at 22:15, 1 year 9 months ago

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM

Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF

published on 05/31/2024 at 12:05, 1 year 9 months ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
PRESS RELEASE

published on 05/31/2024 at 12:00, 1 year 9 months ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF

published on 05/31/2024 at 07:10, 1 year 9 months ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 1 year 9 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 1 year 9 months ago

Sanofi Completes Acquisition of Inhibrx, Inc.

Acquisition Sanofi Rare Diseases Inhibrx SAR447537

Accesswire

Published on 03/17/2026 at 21:30, 33 minutes ago

Rainy Mountain Announces Appointment of Colton Griffith to Board of Directors
Published on 03/17/2026 at 21:10, 53 minutes ago

BTU Announces Financing
Published on 03/17/2026 at 13:30, 8 hours 33 minutes ago

Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 8 hours 33 minutes ago

Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 9 hours 3 minutes ago

Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland

View all ACCESSWIRE

EQS Group

Published on 03/17/2026 at 21:21, 42 minutes ago

KION GROUP AG successfully places a bond of € 500 million
Published on 03/17/2026 at 20:55, 1 hour 7 minutes ago

EQS-Adhoc: thyssenkrupp nucera lowers its sales and EBIT outlook for the Group and the gH2 segment for FY 2025/26 due to higher project costs
Published on 03/17/2026 at 18:07, 3 hours 56 minutes ago

POS-Transaction in Own Shares
Published on 03/17/2026 at 17:58, 4 hours 5 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 17:45, 4 hours 18 minutes ago

FIGEAC AÉRO: THREE NEW WINS IN MEXICO

Les Echos

Published on 03/17/2026 at 07:00, 15 hours 3 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 4 hours ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 4 hours ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 4 hours ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 1 day 4 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE